Reading CGNX? Track it free: the weekly brief, plus an alert if the thesis breaks. No credit card.
Track CGNX free→Reading CGNX? Track it free: the weekly brief, plus an alert if the thesis breaks. No credit card.
Track CGNX free→
NASDAQInformation TechnologyScientific & Technical InstrumentsSnapshot 2026-06-16
Recent financial performance is holding in the top half of its industry — the reason to own it looks intact.
Recent financial performance is strong, while earnings quality and management's track record are neutral. Risk is moderate, and the sector backdrop is a tailwind, with CGNX trading above typical levels compared to its peers. Peer multiples imply a price about 78% below where it trades (it looks expensive on this basis); the read is expensive, growth-justified, as it is rich on today's multiple, but the three-year horizon reads cheaper once expected earnings growth is included. If CGNX cuts guidance on the next call, that would be a meaningful negative. This read is provisional.
Daily closes. Earnings/event dots are placed inline.
A consensus fair price across 6 valuation methods, at three horizons. Current price $65.41. Estimates are diagnostics, not price targets. Short-horizon estimates are close to coin-flips, so confidence is a method-agreement read, not a prediction.
No-growth: today's peer multiple on trailing earnings. The headline read.
Embeds projected growth. Leans optimistic by design. Upside context.
We take the 12-month fair value above and grade our own number — how the market prices this name versus what we'd justify, and where the two diverge.
At $65 the market pays 55× p/e — above the 28× p/e peer median but in line with its own 52× history. That premium reflects a durable franchise our peer-anchored $37 fair value understates; treat the 'expensive vs peers' read with low confidence. Analysts: $50–$80. Not investment advice.
One valuation read at a 12-month horizon, plus how price compares to peers and the company's own history.
The market is pricing in roughly 78% near-term growth, well above our forecast of about 7%. This describes what's priced in, not a forecast of the move.
Only expensive valuation — not the full expensive x weak x turbulent stack. Regime (Mania) does not concentrate fragility.
For similar setups historically (n=20,154): about 33% saw a 20%+ drawdown, and roughly 76% of those did not recover within the year. These are historical base rates for the cohort, not a forecast of this stock.
Each factor is a parallel diagnostic with a clear read of what it shows and how names like it have historically fared. Never aggregated into a single score.
Operating income rose in 2 of the last 3 quarter-over-quarter moves. Historically, Information Technology names rated strong grew net income 73% of the time over the next year (vs 58% for the rest of the cohort, n=2777).
Over the trailing year it converted 1.75x of net income into operating cash flow. Historically, Information Technology names rated neutral grew net income 62% of the time over the next year (vs 58% for the rest of the cohort, n=2831).
Most sensitive to the broad stock market.
Not enough signal to read sensitivity to the US dollar, real (inflation-adjusted) rates, long-term interest rates, Fed net liquidity.
The next print and the backdrop around it (sector regime and the AI cycle). Context for the path, not a forecast of returns.
EPS estimate $0.31 → $0.42 (+35.7% / 30d). 16 raised, 0 cut, 18 covering analysts.
1 upgrade, 0 downgrades / 30d, 0 maintained. 76% of analysts rate Buy.
2 PT revisions / 30d. Avg target 13.5% above current price.
Market and fundamentals agree. Analysts are positioned bullishly on a fundamentally strong name.
How management runs the business: capital, margins, balance sheet, and how reliably they guide and deliver.
A guidance track record builds as the company issues and delivers on guidance.
What a normal day, a bad day, and the worst of the last year would mean for a $10,000 position.
On a typical day, $10k can swing ±$186.
How much price usually moves either way.
On a bad day, this stock has moved -$358.
A rough but not unusual down day (about the 95th percentile).
In the worst 12 months, $10k could have lost $2,786.
Deepest peak-to-trough drop in the last year.
Past results, not a forecast. Not investment advice.
The most important moves since the prior daily snapshot.
No material changes since the prior snapshot.
as of 2026-06-16
Specific, dated things to watch for, each with what would confirm it and what would prove it wrong.
Why it matters: Lower guidance may mean less demand or problems with execution. This could hurt growth.
Confirms:Q2 2026 revenue guidance below $280 million.
Disproves:Q2 2026 revenue guidance at or above $300 million.
Recent news graded against this company's own objectives — whether it reinforces or challenges the thesis, and how confirmed it is.
Threatens: Increase revenue growth
Logistics spending decline impacts revenue growth potential.
Conditional scenarios: if X happens, the view would shift in this direction. These are not predictions.
Recent SEC 8-K filings ranked by likely impact, confidence, and recency.
of this Current Report on Form 8-K, including the Exhibit attached hereto, shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, nor shall it be deemed to be incorporated by reference in any filing under the Securities Act of 1933 or the Securities Exchange Act of 1934, regardless of any general incorporation language in such filing.
Whether the overall read has been drifting up or down lately, and how it's changed since last week.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
Long-thesis check; widest uncertainty.
$50.00 – $80.00 (median $72.00) · 13 analysts · as of 2026-05-26
Looks more expensive than peers.
Around its own typical valuation.
Trailing four: 2025-Q1, 2025-Q2, 2025-Q3, 2026-Q1
A side-by-side read on sector standing, valuation, and risk versus Electronic Equipment & Instruments.
| Stock | Sector standing | Valuation | Risk |
|---|---|---|---|
CGNX Cognex | Above typical Show detailsSector percentile: 72 of 100 | expensive | moderate |
KEYS Keysight Technologies | Above typical Show detailsSector percentile: 90 of 100 | expensive | moderate |
ROP Roper Technologies | Above typical Show detailsSector percentile: 93 of 100 | inexpensive | elevated |
TDY Teledyne Technologies | Above typical Show detailsSector percentile: 76 of 100 | full | moderate |
TRMB Trimble Inc. | Above typical Show detailsSector percentile: 94 of 100 | inexpensive | moderate |
5 material management or governance events in the past 24 months, led by executive changes. Historically, Information Technology names rated neutral grew net income 64% of the time over the next year (vs 57% for the rest of the cohort, n=1040).
Not investment advice. As of 2026-06-16.
via XLK
Tailwind = sector leading the S&P 500; headwind = trailing. Both can be constructive. Historically, headwind regimes have averaged stronger forward returns than tailwind.
Context label only: describes the market state (e.g. real bear vs narrative panic, healthy uptrend vs late-stage froth). It is not a per-ticker buy/sell signal and does not predict factor performance.
Not investment advice. As of 2026-06-16.
Priorities management has stated in recent disclosures, with status and evidence drawn from earnings calls, filings, and press releases.
Focus on increasing revenue growth as a key strategic priority.
Enhance operating income through cost management and efficiency improvements.
Focus on enhancing gross profit margins through operational efficiencies.
Why it matters: Strong sales growth in AI products would support Cognex's strategy and tech leadership.
Confirms:Sales of AI vision products increase by more than 20% year over year in Q2.
Disproves:Sales of AI vision products grow less than 10% year over year in Q2.
Why it matters: Hitting this target shows good management. It could also increase profits.
Confirms:Cognex reports saving $35 to $40 million each year.
Disproves:Cognex fails to meet the cost reduction target by the end of 2026.
Why it matters: A higher margin shows good cost control and efficiency. This can boost investor trust.
Confirms:Adjusted EBITDA margin is over 31% in Q2 2026.
Disproves:Adjusted EBITDA margin falls below 28% in Q2 2026.
Other Events On May 6, 2026, the Company announced that its Board of Directors declared a quarterly cash dividend of $0.085 per share. The dividend is payable on June 4, 2026, to all shareholders of record as of the close of business on May 21, 2026.
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers On April 29, 2026, the Board of Directors of Cognex Corporation (the “Company”) determined that, based on the evolution of his role with the Company, Joerg Kuechen will no longer be deemed an “executive officer” of the Company within the meaning of Rule 3b-7 under the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or an “officer”…
Changes in Registrant’s Certifying Accountant On October 29, 2025, the Audit Committee of the Board of Directors of the Company notified GT, the Company’s then independent registered public accounting firm, that the Audit Committee selected KPMG as the Company’s independent registered public accounting firm for the Company’s fiscal year ending December 31, 2026, subject to completion of KPMG’s standard client acceptance procedures and execution of an engagement letter. GT was previously engag…
of this Current Report on Form 8-K, including the Exhibit attached hereto, shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, nor shall it be deemed to be incorporated by reference in any filing under the Securities Act of 1933 or the Securities Exchange Act of 1934, regardless of any general incorporation language in such filing.